Patents by Inventor Nicole Faulhaber

Nicole Faulhaber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8617560
    Abstract: The present invention relates to peptides or pretide derivatives of the 65kD lower matrix phosphoprotein of human cytomegalovirus. The peptides disclosed are useful for determining whether subjects have een exposed to human cytomegalovirus. Methods for using these peptides or derivatives thereof to determine the peptide-induced production of interferon-? and/or TNF-? in CD8+ T cells isolated from subjects are also disclosed.
    Type: Grant
    Filed: March 28, 2006
    Date of Patent: December 31, 2013
    Inventors: Florian Kern, Hans-Dieter Volk, Petra Reinke, Nicole Faulhaber, Ingolf-Pascal Surel, Elham Khatamzas
  • Patent number: 7994096
    Abstract: The invention relates to a method for the antigen-specific stimulation of T-lymphocytes with a synthetic peptide library, by preparing a plurality of peptides, each of said peptides comprising a fragment less than the whole of the total amino acid sequence of the antigen, each of said peptides being a minimum of 9 amino acid residues (AAs) in length, and the amino acid sequence of each peptide overlapping with the amino acid sequence of at least one other of said peptides; combining a plurality of the peptides from a) into a peptide library, said peptide library comprises a plurality of the peptides selected such that their collective overlapping amino acid sequences span the total amino acid sequence of the antigen; and incubating a suspension comprising CD8+ T lymphocytes, CD4+ T lymphocytes or a mixture of CD8+ and CD4+ with said peptide library in a single culture run.
    Type: Grant
    Filed: February 17, 2001
    Date of Patent: August 9, 2011
    Inventors: Florian Kern, Hans-Dieter Volk, Petra Reinke, Nicole Faulhaber, Ingolf-Pascal Surel, Elham Khatamzas
  • Publication number: 20060165714
    Abstract: The present invention relates to peptides or pretide derivatives of the 65 kD lower matrix phosphoprotein of human cytomegalovirus. The peptides disclosed are useful for determining whether subjects have een exposed to human cytomegalovirus. Methods for using these peptides or derivatives thereof to determine the peptide-induced production of interferon-? and/or TNF-? in CD8+ T cells isolated from subjects are also disclosed.
    Type: Application
    Filed: March 28, 2006
    Publication date: July 27, 2006
    Inventors: Florian Kern, Hans-Dieter Volk, Petra Reinke, Nicole Faulhaber, Ingolf-Pascal Surel, Elham Khatamzas
  • Patent number: 7041442
    Abstract: The present invention relates to peptides or peptide derivatives of the 65 kD lower matrix phoshpoprotein of human cytomegalovirus. The peptides disclosed are useful for determining whether subjects have been exposed to human cytomegalovirus. Methods for using these peptides or derivatives thereof to determine the peptide-induced production of interferon-? and/or TNF-? in CD8+ T cells isolated from subjects are also disclosed.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: May 9, 2006
    Inventors: Florian Kern, Hans-Dieter Volk, Petra Reinke, Nicole Faulhaber, Ingolf-Pascal Surel, Elham Khatamzas
  • Publication number: 20040106159
    Abstract: The invention relates to a method for the antigen-specific stimulation of T-lymphocytes with synthetic peptide libraries, comprising the following steps: a) dividing the whole amino acid sequence of the antigen into protein fragments with partial amino acid sequences: b) synthesising a peptide library containing these protein fragments: c) incubating a suspension containing CD8− and/or CD4− T-lymphocytes with all of the protein fragments of the peptide library in a single culture batch. The method can be used for immunostimulation of T-lymphocytes of mammals, especially humans, as well as for diagnosis purposes, in order to determine whether a mammal, especially a human being, has previously responded to a specific protein with its/his/her immune system, and the strength of this response.
    Type: Application
    Filed: March 17, 2003
    Publication date: June 3, 2004
    Inventors: Florian Kern, Hans-Dieter Volk, Petra Reinke, Nicole Faulhaber, Ingolf-Pascal Surel, Elham Khatamzas